Basics |
Company: |
Bicycle Therapeutics plc |
IPO Date: |
May 20, 2019 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$840.98M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.66 | 3.01%
|
Avg Daily Range (30 D): |
$0.32 | 2.27%
|
Avg Daily Range (90 D): |
$0.48 | 2.53%
|
Institutional Daily Volume |
Avg Daily Volume: |
.2M |
Avg Daily Volume (30 D): |
.28M |
Avg Daily Volume (90 D): |
.38M |
Trade Size |
Avg Trade Size (Sh.): |
94 |
Avg Trade Size (Sh.) (30 D): |
80 |
Avg Trade Size (Sh.) (90 D): |
99 |
Institutional Trades |
Total Inst.Trades: |
1,042 |
Avg Inst. Trade: |
$2.06M |
Avg Inst. Trade (30 D): |
$2.5M |
Avg Inst. Trade (90 D): |
$2.2M |
Avg Inst. Trade Volume: |
.09M |
Avg Inst. Trades (Per Day): |
2 |
Market Closing Trades |
Avg Closing Trade: |
$1.2M |
Avg Closing Trade (30 D): |
$1.32M |
Avg Closing Trade (90 D): |
$.92M |
Avg Closing Volume: |
44.94K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-3.28
|
$-.74
|
$-.77
|
Diluted EPS
|
$-3.28
|
$-.74
|
$-.77
|
Revenue
|
$ 36.9M
|
$ 2.68M
|
$ 9.36M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -166.28M
|
$ -50.8M
|
$ -39.81M
|
Operating Income / Loss
|
$ -196.44M
|
$ -63.85M
|
$ -46.65M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ 316.4M
|
$ -72.2M
|
$ 504.56M
|
PE Ratio
|
|
|
|
|